Biopharma Week in Review - December 9, 2024
269 Views12 Dec 2024 02:24
Issuer-paid
We review last week’s biopharma news for meaningful clinical data, regulatory updates, research innovation, and M&A. Last week, BIOA discontinued its lead obesity study
What is covered in the Full Insight:
- Review of Biopharma News
- BioAge Labs Obesity Study Discontinuation
- Janux Therapeutics Prostate Cancer Data
- PTC Therapeutics and Novartis Deal
- Senti Biosciences AML Trial Results
SUMMARY
(Sign Up to Access)Full Insight
(Paid Plans Only, 9-minute read)
Top Unpaywalled Insights
More »Discussions
(Paid Plans Only)